Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience

enthalten in: OncoTargets and therapy | 2019

von Cavanna, L. | Stroppa, E. | Citterio, C. | +5